Mati Therapeutics Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-07-027/2/26 | Amended | $2,649,815 | $465,640 | Equity Only | 06b | SEC linkSEC |
| 2025-10-0810/8/25 | New | $9,867,695 | $9,867,695 | Equity Only | 06b | SEC linkSEC |
| 2025-09-239/23/25 | New | $2,184,175 | $2,184,175 | Equity Only | 06b | SEC linkSEC |
| 2019-05-245/24/19 | New | $165,030 | $165,030 | Equity Only | 06b | SEC linkSEC |
| 2018-10-1610/16/18 | New | $50,000 | $50,000 | Equity Only | 06b | SEC linkSEC |
| 2014-10-1010/10/14 | New | $150,000 | $150,000 | Equity Only | 06c | SEC linkSEC |
| 2013-04-154/15/13 | New | $1,310,000 | $1,310,000 | Equity Only | 06 | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Robert Butchofsky | Director, Executive |
| Robert Lee Butchofsky Ii | Director, Executive |
| Dave Fellows | Director |
| Ken Jones | Director |
| Linda Lupini | Director |
| Jim Mazzo | Director |
| Peter Mc Donnell | Director |
| Christopher Muller | Director, Executive |
| Chris Muller | Director, Executive |
| Cameron Nelson | Executive |
| Joseph Tortorice Iii | Director |
| Deepank Utkede | Director, Executive |
| Deepank Utkhede | Director |
Industry: Biotechnology (See others in industry)
Address:
101 Colorado Street Suite 2409
Austin, TX, 78701
Phone: 512-720-1333
Austin, TX, 78701
Phone: 512-720-1333